Nongnuj Tanphaichitr of the Ottawa Hospital Research Institute (formerly Ottawa Health Research Institute) in Canada will research whether the antimicrobial peptide LL-37 can be used simultaneously as a contraceptive and an anti-HIV treatment. LL-37 binds to specific sites on sperm which are thought not only to play key roles in egg fertilization but also interact with gp120 used by HIV to gain entry into cells.
Grant ID
OPP1024509
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False